Ignite Creation Date:
2024-05-06 @ 1:42 PM
Last Modification Date:
2024-10-26 @ 1:18 PM
Study NCT ID:
NCT04094610
Status:
RECRUITING
Last Update Posted:
2024-04-10
First Post:
2019-09-12
Brief Title:
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK ROS1 OR NTRK1-3 Alterations
Sponsor:
Organization:
Turning Point Therapeutics Inc